← Leaderboards
Marco E Zamora
Drexel University
$186,002
Attributed
$186,002
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2020–23$50K$37.5K$25K$12.5K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$186,002 · 1
By mechanism
F31$186,002 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Critical Illness”
- Oliver Brand · Emory University$18,504,645
- Vanessa Rivera-Amill · Ponce School Of Medicine$13,362,042
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Mayur B Patel · Vanderbilt University Medical Center$9,075,045
- Hemali Phatnani · New York University School Of Medicine$8,533,907
Research focus
Critical IllnessCytokineComplexAcute DiseaseAcuteAlveolarAdmission ActivityClinical TrialsAngiopoietinsAngpt1 GeneAnimal ModelAntibodiesAwarenessBasic ScienceBindingBlood CapillariesBlood VesselsAngiopoietin-2Bronchoalveolar Lavage FluidCellsCell Surface ProteinsCell TypeClinical TreatmentDesign
Grant awards (4)
Nanoscale drug carriers for the treatment of Acute Respiratory Distress Syndrome (ARDS).$47,694
F31 · FY2023 · HL · contact PI
Nanoscale drug carriers for the treatment of Acute Respiratory Distress Syndrome (ARDS).$46,752
F31 · FY2022 · HL · contact PI
Nanoscale drug carriers for the treatment of Acute Respiratory Distress Syndrome (ARDS).$46,036
F31 · FY2021 · HL · contact PI
Nanoscale drug carriers for the treatment of Acute Respiratory Distress Syndrome (ARDS).$45,520
F31 · FY2020 · HL · contact PI